164:
22:
237:
123:
Inoue T, Nishiki R, Kageyama M, et al. (February 2005). "Long-term benefits of monteplase before coronary angioplasty in acute myocardial infarction".
213:
232:
206:
80:
Inoue T, Nishiki R, Kageyama M, Node K (2005). "Therapeutic potential of monteplase in acute myocardial infarction".
199:
60:
171:
105:
140:
97:
132:
89:
163:
36:
35:
Please expand the article to include this information. Further details may exist on the
183:
179:
226:
93:
109:
136:
144:
101:
21:
175:
15:
187:
207:
59:is an antithrombic proposed for use in acute
8:
214:
200:
238:Blood and blood forming organ drug stubs
72:
7:
160:
158:
14:
162:
94:10.2165/00129784-200505040-00002
33:about indication, producer, ....
20:
1:
137:10.1016/j.amjcard.2004.09.061
186:. You can help Knowledge by
254:
157:
174:article relating to the
31:is missing information
233:Antithrombotic agents
82:Am J Cardiovasc Drugs
61:myocardial infarction
180:blood forming organs
195:
194:
54:
53:
245:
216:
209:
202:
166:
159:
149:
148:
120:
114:
113:
77:
49:
46:
40:
24:
16:
253:
252:
248:
247:
246:
244:
243:
242:
223:
222:
221:
220:
155:
153:
152:
122:
121:
117:
79:
78:
74:
69:
50:
44:
41:
34:
25:
12:
11:
5:
251:
249:
241:
240:
235:
225:
224:
219:
218:
211:
204:
196:
193:
192:
167:
151:
150:
125:Am. J. Cardiol
115:
71:
70:
68:
65:
52:
51:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
250:
239:
236:
234:
231:
230:
228:
217:
212:
210:
205:
203:
198:
197:
191:
189:
185:
181:
177:
173:
168:
165:
161:
156:
146:
142:
138:
134:
130:
126:
119:
116:
111:
107:
103:
99:
95:
91:
88:(4): 225–31.
87:
83:
76:
73:
66:
64:
62:
58:
48:
45:November 2017
38:
32:
29:This article
27:
23:
18:
17:
188:expanding it
169:
154:
131:(4): 506–8.
128:
124:
118:
85:
81:
75:
56:
55:
42:
30:
227:Categories
67:References
57:Monteplase
37:talk page
145:15695140
110:26417952
102:15984905
143:
108:
100:
182:is a
176:blood
170:This
106:S2CID
184:stub
178:and
172:drug
141:PMID
98:PMID
133:doi
90:doi
229::
139:.
129:95
127:.
104:.
96:.
84:.
63:.
215:e
208:t
201:v
190:.
147:.
135::
112:.
92::
86:5
47:)
43:(
39:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
